New treatment option for Postoperative Pain
Official title Retrolaminar Analgesia for LuMbar Surgery
ClinicalTrials.gov ID: NCT07334288
What this study is testing
- What it's testing
- This randomized controlled trial evaluates the effectiveness of ultrasound-guided retrolaminar nerve block in addition to standard multimodal analgesia for postoperative pain management in patients undergoing lumbar spine surgery. Fifty patients will be randomly assigned to receive either the retrolaminar block combined with standard pain management or standard pain management alone.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adult patients aged 18-80 years
- Scheduled for elective lumbar spine surgery (with instrumentation)
- American Society of Anesthesiologists (ASA) physical status I-III
- Willing and able to provide written informed consent
- Able to use patient-controlled analgesia (PCA) device
You likely can't join if
- Refusal to participate in the study
- Known allergy to local anesthetics (bupivacaine - levobupivacaine - lidocaine) or any study medication
- Contraindication to regional anesthesia (infection at injection site, coagulopathy)
- Chronic opioid use (daily use for \>3 months prior to surgery)
- Severe psychiatric disorder that precludes informed consent
- Emergency surgery
See the full eligibility criteria
- Adult patients aged 18-80 years
- Scheduled for elective lumbar spine surgery (with instrumentation)
- American Society of Anesthesiologists (ASA) physical status I-III
- Willing and able to provide written informed consent
- Able to use patient-controlled analgesia (PCA) device
- Refusal to participate in the study
- Known allergy to local anesthetics (bupivacaine - levobupivacaine - lidocaine) or any study medication
- Contraindication to regional anesthesia (infection at injection site, coagulopathy)
- Chronic opioid use (daily use for \>3 months prior to surgery)
- Severe psychiatric disorder that precludes informed consent
- Emergency surgery
- Diabetes mellitus with preoperative glucose \>180 mg/dl
- Pregnancy or breastfeeding
- Body mass index (BMI) \>40 kg/m²
- Reoperation or revision of the same level of previous spinal surgery
The study team makes the final eligibility decision.
Where it's taking place
- Santiago, Santiago Metropolitan, Chile
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Santiago, Santiago Metropolitan, Chile. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.